-
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
(PA-18-837)
Office of the Director, NIH
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Application Receipt Date(s): Applications are accepted on a rolling basis at any time starting 30 days after the Open Date until the expiration date, unless otherwise noted in Institute specific language. Please consult with Scientific contacts listed in Section VII.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15 - Clinical Trial Not Allowed)
(PAR-18-834)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): September 18, 2018, September 18, 2019, September 18, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
(PAR-18-835)
John E. Fogarty International Center
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 7, 2018; November 7, 2019, November 6, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
(PAR-18-836)
John E. Fogarty International Center
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 7, 2018; November 7, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed)
(RFA-AG-19-015)
National Institute on Aging
Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed)
(RFA-AG-19-016)
National Institute on Aging
Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)
(RFA-AI-18-026)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): December 13, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
(RFA-CA-18-025)
National Cancer Institute
Application Receipt Date(s): August 28, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this FOA.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.